LOS ANGELES--(BUSINESS WIRE)--Xcorporeal, Inc. (OTCBB:XCPL) announced today that Victor Gura M.D., its Chief Scientific Officer, will deliver a presentation at The American Society of Nephrology’s (ASN) Renal Week, entitled, “Continuous Renal Replacement Therapy with a Wearable Device,” featuring the first human study conducted in London earlier this year with a prototype of the company’s Wearable Artificial Kidney (WAK). Dr. Gura will present today at 11:30 a.m. Pacific time in room 2022 at the Moscone Center in San Francisco.
